BioCryst Pharmaceuticals Inc (BCRX) – Company Profile and SWOT Analysis
- Pages: 57
- Published: May 2026
- Report Code: MLPH66540FSA
BioCryst Pharmaceuticals Inc (BCRX) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Key Highlights
BioCryst Pharmaceuticals Inc (BioCryst) is a biotechnology company that is primarily focused on discovering and developing oral small-molecule and protein therapeutics for rare diseases. The company's main activities include leveraging structure-guided drug design to create therapies for conditions such as hereditary angioedema (HAE) and complement-mediated diseases. BioCryst's notable products include ORLADEYO, an oral plasma kallikrein inhibitor, and RAPIVAB, an intravenous neuraminidase inhibitor. BioCryst operates through a network of regional offices and collaborates with healthcare professionals to distribute its therapies globally. The company has its operations in the US and Ireland. BioCryst is headquartered in Durham, North Carolina, the US.
Scope
• Detailed information on BioCryst Pharmaceuticals Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting BioCryst Pharmaceuticals Inc in the form of a SWOT analysis
• An in-depth view of the business model of BioCryst Pharmaceuticals Inc including a breakdown and examination of key business segments
• News about BioCryst Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of BioCryst Pharmaceuticals Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess BioCryst Pharmaceuticals Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on BioCryst Pharmaceuticals Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
F. Hoffmann-La Roche Ltd
Daiichi Sankyo Co Ltd
GSK plc
Gilead Sciences Inc
CSL Ltd
Boehringer Ingelheim International GmbH
Quoin Pharmaceuticals Ltd
Intellia Therapeutics Inc
ADARx Pharmaceuticals Inc
Shionogi Inc
Rezolute Inc
Pharvaris NV
EyePoint Inc
Regeneron Pharmaceuticals Inc
Kalvista Pharmaceuticals Inc
UCB SA
Merck & Co Inc
Ionis Pharmaceuticals Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.